In shared decision making, the health care professional does not decide on his or her own which treatment will be administered, but the professional and the patient decide together.
Trudy van der Weijden, professor of Implementation of Clinical Practice Guidelines at Maastricht University: “We are very pleased to have been able to get the conference on this theme to Maastricht. It is a major international event with almost 300 participants from over 20 countries and from many different fields: physicians, nursing scientists and nurses, health scientists, ethicists, epidemiologists, health psychologists and, for the first time, patient representatives in four different countries will participate. We are very proud of this. They can make an important contribution to the discussion.”
The conference attracts a lot of attention in the international medical world and in the press. And that is necessary, according Van der Weijden: “We must spread the message, because it is a movement that deserves to be in the spotlight. When it is applied well, both doctors and patients will benefit from shared decision making.”
What concrete changes does this bring to doctor-patient consultations? "Doctors and patients both have an active role in shared decision making" van der Weijden explains. "Patients can inform themselves about treatment options, through the help of so-called decision aids for example. Health care professionals should offer the decision aids, explain them in understandable language, and listen carefully to the considerations of the patient. National clinical practice guidelines serve as tools and resources to create more consistency in the treatments prescribed by doctors, but they should not be used dogmatically. Doctors should be able to have a flexible interpretation of the guidelines and tailor it to the patient. Shared decision making can provide a framework for that process."
“Deliberation on whether or not to start a treatment, a screening or diagnostic test is done together in a joint decision making process. In this way the patient can take part in deciding whether he or she wishes to be treated according to the first choice option as described in the guidelines themselves, choose an alternative treatment option, or even choose to do something completely different from what is in the guidelines. This is important especially when it comes to deciding between extending life and quality of life. For example, in the treatment of prostate cancer a high dose of radiotherapy has the greatest chance of prolonging life, but also causes unpleasant side effects such as incontinence and impotence. Radiotherapy with a lower dose will prolong life a little less, but there is a much smaller chance of unpleasant side effects. Faced with these dilemmas, everyone makes different choices depending on their personal situation and values," according to Van der Weijden.
The 2011 International Shared Decision Making Conference will be held from 19 to 22 June at the Crowne Plaza Hotel in Maastricht. For more information visit http://www.isdm2011.org
The UM Marketing and Communications department can be contacted at +31 (0)43 388 5222, email firstname.lastname@example.org. For urgent matters outside office hours: +31 (0)6 4602 4992
3rd Symposium on Driving Simulation
23.10.2017 | Virtual Dimension Center Fellbach w. V.
ASEAN Member States discuss the future role of renewable energy
17.10.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)
Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...
University of Maryland researchers contribute to historic detection of gravitational waves and light created by event
On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...
Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.
Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....
Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).
When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...
Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.
How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...
23.10.2017 | Event News
17.10.2017 | Event News
10.10.2017 | Event News
23.10.2017 | Life Sciences
23.10.2017 | Physics and Astronomy
23.10.2017 | Health and Medicine